US OptionsDetailed Quotes
OMIC250221P2500
- 0.00
- 0.000.00%
15min DelayTrading Nov 27 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV88.58%PremiumFeb 21, 2025Expiry Date0.00Intrinsic Value100Multiplier86DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Singular Genomics Stock Discussion
Sign in to post a comment
$Singular Genomics (OMIC.US)$ net cash position $23.1/share
1
2
$Verona Pharma (VRNA.US)$ $Safe & Green Development (SGD.US)$ $Globalstar (GSAT.US)$ $SRM Entertainment (SRM.US)$ $Silo Pharma (SILO.US)$ $ESSA Pharma (EPIX.US)$ $SAG Holdings (SAG.US)$ $Tenaya Therapeutics (TNYA.US)$ $Air Transport Services (ATSG.US)$ $Hanryu Holdings (HRYU.US)$ $Vertex Pharmaceuticals (VRTX.US)$ $Singular Genomics (OMIC.US)$ $Nuwellis (NUWE.US)$ $Vast Renewables (VSTE.US)$
📊⚡️📊
📊⚡️📊
4
$Singular Genomics (OMIC.US)$
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc.
SEC·
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc.
SEC·
2
$Singular Genomics (OMIC.US)$
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC ("Concentra") to acquire all o...
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC ("Concentra") to acquire all o...
$SMX (Security Matters) (SMX.US)$ monday intra-day watchlist considering top performing/high probability setup stocks of last trading day
$Singular Genomics (OMIC.US)$
$Instil Bio (TIL.US)$
$Singular Genomics (OMIC.US)$
$Instil Bio (TIL.US)$
3
$Singular Genomics (OMIC.US)$ Just bought the dip, hoping it runs to $10
No comment yet
BuyLowSellHighTrader : Can enter at this price ?
LuckyLuke OP BuyLowSellHighTrader : before you put any money in here first check/search google, ceo's name and what they have been doing in the past.